One study that analyzed gene expression data of Ly6 family members found that several proteins, including LY6D, are overexpressed across various cancers, and notably, high LY6D expression is associated with poorer survival in patients with bladder cancer, ovarian cancer, and breast cancer 28. Here, LY6D is linked to ovarian carcinoma.